Treatment Options For Fabry Disease
Denmark
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Germany
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Czech Republic
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Cyprus
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Switzerland
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Bulgaria
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Belgium
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Treatment Options For Fabry Disease
Austria
12168451.8
Filed on 2007-05-16
12168451.8
Filed on 2007-05-16
Zenapax (Humanized Antibody Against The IL-2 Receptor Alpha Chain) As A Novel Treatment For Multiple Sclerosis14/792,432
US Application 14/792,432
Filed on 2015-07-06
Filed on 2015-07-06
BIOMARKERS FOR DIAGNOSIS AND MANAGEMENT OF NEURO-IMMUNOLOGICAL DISEASES
Patent Cooperation Treaty
PCT/US2015/045549
Filed on 2015-08-17
PCT/US2015/045549
Filed on 2015-08-17